Ligand-Target Prediction by Structural Network Biology Using nAnnoLyze

PLoS Computational Biology

Volumn 11, Issue 3, 2015, Pages

  Martínez Jiménez, Francisco ^a,b   Marti Renom, Marc A ^a,b,c  

^a Centre Nacional d'Analisi Genomica CNAG   (Spain)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; CLASSIFICATION (OF INFORMATION); DRUG DOSAGE; DRUG INTERACTIONS; FORECASTING; PROTEINS;

DRUG DESIGN; DRUG-DRUG INTERACTIONS; INTERACTION PREDICTION; NETWORK BIOLOGY; PROTEIN INTERACTION; SIDE EFFECT; STRUCTURAL DETAILS; STRUCTURAL NETWORKS; TARGET PREDICTION; TARGET'S IDENTIFICATIONS;

LIGANDS;

ACETYLSALICYLIC ACID; B RAF KINASE; BROMFENAC; CARPROFEN; CD135 ANTIGEN; CYCLIN DEPENDENT KINASE 8; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; DIFLUNISAL; ENALAPRIL; FLURBIPROFEN; IBUPROFEN; KETOPROFEN; KETOROLAC; LUMIRACOXIB; MECLOFENAMIC ACID; MEFENAMIC ACID; NAPROXEN; NEPAFENAC; NIFLUMIC ACID; OXAPROZIN; PROTEOME; SALSALATE; SULINDAC; SUPROFEN; TIAPROFENIC ACID; TOLMETIN; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR 1; LIGAND; PROTEIN; PROTEIN BINDING;

ANNOLYZE; ARTICLE; CLASSIFIER; CONTROLLED STUDY; DRUG BINDING SITE; DRUG PROTEIN BINDING; INTERMETHOD COMPARISON; LIGAND BINDING; MEASUREMENT ACCURACY; MOLECULAR DOCKING; NANNOLYZE; PREDICTION; PROTEIN STRUCTURE; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; BINDING SITE; BIOLOGY; CHEMISTRY; DRUG DEVELOPMENT; HUMAN; METABOLISM; PROCEDURES; PROTEIN DATABASE; SOFTWARE;

BINDING SITES; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; DRUG DISCOVERY; HUMANS; LIGANDS; PROTEIN BINDING; PROTEINS; ROC CURVE; SOFTWARE;

EID: 84926303578     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004157     Document Type: Article

References (60)

1. Hopkins AL, Mason JS, Overington JP, (2006) Can we rationally design promiscuous drugs? Curr Opin Struct Biol 16: 127–136. 16442279
2. Hopkins AL, (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4: 682–690. doi: 10.1038/nchembio.118 18936753
3. Narayan VA, Mohwinckel M, Pisano G, Yang M, Manji HK, (2013) Beyond magic bullets: true innovation in health care. Nat Rev Drug Discov 12: 85–86. doi: 10.1038/nrd3944 23370233
4. Dar AC, Das TK, Shokat KM, Cagan RL, (2012) Chemical genetic discovery of targets and anti-targets for cancer polypharmacology. Nature 486: 80–84. doi: 10.1038/nature11127 22678283
5. Roth BL, Sheffler DJ, Kroeze WK, (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3: 353–359. 15060530
6. Knight ZA, Lin H, Shokat KM, (2010) Targeting the cancer kinome through polypharmacology. Nat Rev Cancer 10: 130–137. doi: 10.1038/nrc2787 20094047
7. Lecca P, Priami C, (2013) Biological network inference for drug discovery. Drug Discov Today 18: 256–264. doi: 10.1016/j.drudis.2012.11.001 23147668
8. Harrold JM, Ramanathan M, Mager DE, (2013) Network-based approaches in drug discovery and early development. Clin Pharmacol Ther 94: 651–658. doi: 10.1038/clpt.2013.176 24025802
9. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, et al. (2009) Predicting new molecular targets for known drugs. Nature 462: 175–181. doi: 10.1038/nature08506 19881490
10. Yabuuchi H, Niijima S, Takematsu H, Ida T, Hirokawa T, et al. (2011) Analysis of multiple compound-protein interactions reveals novel bioactive molecules. Mol Syst Biol 7: 472. doi: 10.1038/msb.2011.5 21364574
11. Yamanishi Y, Araki M, Gutteridge A, Honda W, Kanehisa M, (2008) Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 24: i232–240. doi: 10.1093/bioinformatics/btn162 18586719
12. Yamanishi Y, Kotera M, Kanehisa M, Goto S, (2010) Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics 26: i246–254. doi: 10.1093/bioinformatics/btq176 20529913
13. Chen X, Liu MX, Yan GY, (2012) Drug-target interaction prediction by random walk on the heterogeneous network. Mol Biosyst 8: 1970–1978. doi: 10.1039/c2mb00002d 22538619
14. van Laarhoven T, Marchiori E, (2013) Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile. PLoS One 8: e66952. 23840562
15. van Laarhoven T, Nabuurs SB, Marchiori E, (2011) Gaussian interaction profile kernels for predicting drug-target interaction. Bioinformatics 27: 3036–3043. doi: 10.1093/bioinformatics/btr500 21893517
16. Alaimo S, Pulvirenti A, Giugno R, Ferro A, (2013) Drug-target interaction prediction through domain-tuned network-based inference. Bioinformatics 29: 2004–2008. doi: 10.1093/bioinformatics/btt307 23720490
17. Emig D, Ivliev A, Pustovalova O, Lancashire L, Bureeva S, et al. (2013) Drug target prediction and repositioning using an integrated network-based approach. PLoS One 8: e60618. doi: 10.1371/journal.pone.0060618 23593264
18. Wang Y, Zeng J, (2013) Predicting drug-target interactions using restricted Boltzmann machines. Bioinformatics 29: i126–134. doi: 10.1093/bioinformatics/btt234 23812976
19. Cheng AC, Coleman RG, Smyth KT, Cao Q, Soulard P, et al. (2007) Structure-based maximal affinity model predicts small-molecule druggability. Nat Biotechnol 25: 71–75. 17211405
20. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, et al. (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30: 2785–2791. doi: 10.1002/jcc.21256 19399780
21. Li H, Gao Z, Kang L, Zhang H, Yang K, et al. (2006) TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res 34: W219–224. 16844997
22. Reardon S, (2013) Project ranks billions of drug interactions. Nature 503: 449–450. doi: 10.1038/503449a 24284710
23. Marti-Renom MA, Rossi A, Al-Shahrour F, Davis FP, Pieper U, et al. (2007) The AnnoLite and AnnoLyze programs for comparative annotation of protein structures. BMC Bioinformatics 8 Suppl 4: S4. 17570147
24. Kalinina OV, Wichmann O, Apic G, Russell RB, (2011) Combinations of protein-chemical complex structures reveal new targets for established drugs. PLoS Comput Biol 7: e1002043. doi: 10.1371/journal.pcbi.1002043 21573205
25. Morris RJ, Najmanovich RJ, Kahraman A, Thornton JM, (2005) Real spherical harmonic expansion coefficients as 3D shape descriptors for protein binding pocket and ligand comparisons. Bioinformatics 21: 2347–2355. 15728116
26. Najmanovich R, Kurbatova N, Thornton J, (2008) Detection of 3D atomic similarities and their use in the discrimination of small molecule protein-binding sites. Bioinformatics 24: i105–111. doi: 10.1093/bioinformatics/btn263 18689810
27. Hoffmann B, Zaslavskiy M, Vert JP, Stoven V, (2010) A new protein binding pocket similarity measure based on comparison of clouds of atoms in 3D: application to ligand prediction. BMC Bioinformatics 11: 99. doi: 10.1186/1471-2105-11-99 20175916
28. Roy A, Yang J, Zhang Y, (2012) COFACTOR: an accurate comparative algorithm for structure-based protein function annotation. Nucleic Acids Res 40: W471–477. doi: 10.1093/nar/gks372 22570420
29. Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, et al. (2002) The Protein Data Bank. Acta Crystallogr D Biol Crystallogr 58: 899–907. 12037327
30. Orti L, Carbajo RJ, Pieper U, Eswar N, Maurer SM, et al. (2009) A kernel for open source drug discovery in tropical diseases. PLoS Negl Trop Dis 3: e418. doi: 10.1371/journal.pntd.0000418 19381286
31. Martinez-Jimenez F, Papadatos G, Yang L, Wallace IM, Kumar V, et al. (2013) Target prediction for an open access set of compounds active against Mycobacterium tuberculosis. PLoS Comput Biol 9: e1003253. doi: 10.1371/journal.pcbi.1003253 24098102
32. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36: D901–906. 18048412
33. van Laarhoven T, Marchiori E (2014) Biases of drug–target interaction network data.
34. Fitzpatrick FA, (2004) Cyclooxygenase enzymes: regulation and function. Curr Pharm Des 10: 577–588. 14965321
35. Hawkey CJ, (2001) COX-1 and COX-2 inhibitors. Best Pract Res Clin Gastroenterol 15: 801–820. 11566042
36. Peng CL, Guo W, Ji T, Ren T, Yang Y, et al. (2009) Sorafenib induces growth inhibition and apoptosis in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK signaling pathway. Cancer Biol Ther 8: 1729–1736. 19633425
37. Liu L, Cao Y, Chen C, Zhang X, McNabola A, et al. (2006) Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 66: 11851–11858. 17178882
38. Ravandi F, Cortes JE, Jones D, Faderl S, Garcia-Manero G, et al. (2010) Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia. J Clin Oncol 28: 1856–1862. doi: 10.1200/JCO.2009.25.4888 20212254
39. Ravandi F, Alattar ML, Grunwald MR, Rudek MA, Rajkhowa T, et al. (2013) Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation. Blood 121: 4655–4662. doi: 10.1182/blood-2013-01-480228 23613521
40. Eggert US, (2013) The why and how of phenotypic small-molecule screens. Nat Chem Biol 9: 206–209. doi: 10.1038/nchembio.1206 23508174
41. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, et al. (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465: 305–310. doi: 10.1038/nature09107 20485427
42. Ballell L, Bates RH, Young RJ, Alvarez-Gomez D, Alvarez-Ruiz E, et al. (2013) Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis. ChemMedChem.
43. Minie M, Chopra G, Sethi G, Horst J, White G, et al. (2014) CANDO and the infinite drug discovery frontier. Drug Discov Today 19: 1353–1363. doi: 10.1016/j.drudis.2014.06.018 24980786
44. Berman HM, Coimbatore Narayanan B, Di Costanzo L, Dutta S, Ghosh S, et al. (2013) Trendspotting in the Protein Data Bank. FEBS Lett 587: 1036–1045. doi: 10.1016/j.febslet.2012.12.029 23337870
45. Norvell JC, Berg JM, (2007) Update on the protein structure initiative. Structure 15: 1519–1522. 18073099
46. Khafizov K, Madrid-Aliste C, Almo SC, Fiser A, (2014) Trends in structural coverage of the protein universe and the impact of the Protein Structure Initiative. Proc Natl Acad Sci U S A 111: 3733–3738. doi: 10.1073/pnas.1321614111 24567391
47. Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL, (2012) Quantifying the chemical beauty of drugs. Nat Chem 4: 90–98. doi: 10.1038/nchem.1243 22270643
48. Stuart AC, Ilyin VA, Sali A, (2002) LigBase: a database of families of aligned ligand binding sites in known protein sequences and structures. Bioinformatics 18: 200–201. 11836232
49. Konc J, Janezic D, (2010) ProBiS: a web server for detection of structurally similar protein binding sites. Nucleic Acids Res 38: W436–440. doi: 10.1093/nar/gkq479 20504855
50. Pieper U, Webb BM, Dong GQ, Schneidman-Duhovny D, Fan H, et al. (2014) ModBase, a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res 42: D336–346. doi: 10.1093/nar/gkt1144 24271400
51. Pieper U, Webb BM, Barkan DT, Schneidman-Duhovny D, Schlessinger A, et al. (2011) ModBase, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res 39: D465–474. doi: 10.1093/nar/gkq1091 21097780
52. Pieper U, Eswar N, Stuart AC, Ilyin VA, Sali A, (2002) MODBASE, a database of annotated comparative protein structure models. Nucleic Acids Res 30: 255–259. 11752309
53. Eswar N, John B, Mirkovic N, Fiser A, Ilyin VA, et al. (2003) Tools for comparative protein structure modeling and analysis. Nucleic Acids Res 31: 3375–3380. 12824331
54. Shen MY, Sali A, (2006) Statistical potential for assessment and prediction of protein structures. Protein Sci 15: 2507–2524. 17075131
55. Eramian D, Shen MY, Devos D, Melo F, Sali A, et al. (2006) A composite score for predicting errors in protein structure models. Protein Sci 15: 1653–1666. 16751606
56. Ortiz AR, Strauss CE, Olmea O, (2002) MAMMOTH (matching molecular models obtained from theory): an automated method for model comparison. Protein Sci 11: 2606–2621. 12381844
57. Dijkstra EW, (1959) A note on two problems in connexion with graphs. Numerische Mathematik 1: 269–271.
58. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, et al. (2009) The WEKA Data Mining Software: An Update. SIGKDD Explorations 11.
59. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25–29. 10802651
60. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, et al. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 27: 29–34. 9847135